Mylan Can't Escape EpiPen Distributors' Antitrust Claims
A Minnesota federal judge has refused to throw out a proposed class action that accuses drugmaker Mylan Inc. of paying bribes and kickbacks to a group of pharmacy benefit managers and...To view the full article, register now.
Already a subscriber? Click here to view full article